ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Dec 5, 2016
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Sale
Common Stock
2016-12-01$20.76/sh−4,855$100,774→ 76,558 total
Footnotes (2)
- [F1]Sales pursuant to a 10b5-1 plan.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.30 to $21.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.